화학공학소재연구정보센터
Journal of Polymer Science Part A: Polymer Chemistry, Vol.42, No.19, 4906-4915, 2004
Investigation of the solid phase synthesis of tyrosine-derived diphenol monomers with resin-bound carbodiimide coupling reagents
Tyrosine-derived pseudo-polypeptides have recently been established as potential biomaterials. The bulk production of these polymers is dependant upon the convenient synthesis of tyrosine-derived diphenolic monomers. Suitable solution phase methods for the synthesis of such monomers, with transient activated esters, have been reported previously by Kohn, J.; Langer, R. In Biomaterials Science: An Introduction to Materials in Medicine; Ratner, B. D.; Hoffman, A. S.; Schoen, F. J.; Lemons, J. E., Eds.; Academic Press: New York, 1996; pp 64-72. However, for all the methods reported by them, purification and isolation of the diphenol monomer involves rigorous extraction, column purification, or an extensive aqueous workup. These may lead to the incorporation of solvent-based as well as inorganic impurities and also may lead to difficulties in the process scale-up. In this article, an alternate and relatively more convenient method for the synthesis of tyrosine-based diphenol monomers is reported. This involved the investigation of polymer resin-bound carbodiimide in the solid-phase synthesis of L-tyrosine-based diphenolic monomers. This method was found to eliminate the need for rigorous purification processes and was found to maintain reasonable yield as well as maintain purity of the final monomer product. The monomer was able to produce polymers of a reasonably high-molecular-weight and a narrow polydispersity. The amide bond formation by such a polymer-tethered reagent can be described to follow a reverse-Merrifield sense and the method is relatively convenient to scale up. The L-tyrosine-based diphenolic monomeric compound formed by this method was analyzed by NMR, Fourier transform infrared, and elemental microanalysis techniques for chemical structure and composition. (C) 2004 Wiley Periodicals, Inc.